Press Releases Archive

June 4, 2020 | New York, NY

Global Survey Finds Nearly Half of Physicians Who Have Seen Children with Suspected Pediatric Multisystem Inflammatory Syndrome Have Seen These Cases in Past Week

Survey Data and Experiences in Other Countries Suggest United States Could See Surge in Cases of Pediatric Disease Linked to COVID-19

May 29, 2020 | New York, NY

Non-invasive oxygen therapies delay or prevent intubation but are believed to aerosolize coronavirus by 80% of global physicians treating COVID-19 in hospitals

34% of COVID-19 treating physicians still believe ventilators are used too rapidly according to their hospital protocols

May 21, 2020 | New York, NY

Sermo reports: Worldwide Remdesivir usage grows, but 67% of doctors believe Remdesivir would be most effective administered earlier, before patients become severely ill

75% of global physicians treating COVID-19 rate Remdesivir with low to moderate efficacy and find current Remdesivir indication confusing

Plasma perceived as most effective treatment for the last five weeks

May 14, 2020 | New York, NY

Sermo Reports: 85% of Worldwide Physicians See False Negative Test Results with COVID-19 Patients and 9% Have Seen at Least One Case of Re-Infection

As States Ease Up on Restrictions, Accurate Testing and Tracing are Critical to Stopping Disease Spread and Virus Reinfection

May 7, 2020 | New York, NY

Sermo reports: COVID-19 treatment trends over 6 weeks and 33,700 interviews: Usage, efficacy and safety perceptions of most-used therapies

High demand for Plasma and Remdesivir

Currently, 55% of global physicians use Hydroxychloroquine, 24% use Tocilizumab, 21% use Remdesivir, 17% use Plasma

May 4, 2020 | New York, NY

Sermo Reports: 50% of Highly Experienced COVID Treaters Believe COVID-19 is More of an “Oxygen Failure” Disease vs. a Respiratory Disease Leading to ARDS; 48% Believe Ventilators Used Too Rapidly

Physicians share insights on potential new clinical guidelines, ventilation protocol changes and alternative oxygen therapies

May 1, 2020 | New York, NY

Sermo Reports: 58% of US Physicians Report HCPs Testing Positive for COVID-19 in Their Hospital/Clinic; Korea, China, Japan Report the Least COVID-19 Infections Among Colleagues

Florida, Texas, Virginia, and Ohio Have Seen Sharpest Increase In Physicians Reporting Infections Among HCP Colleagues; Globally, Russia, Mexico, Brazil & Great Britain Have Seen Sharpest Increase

April 27, 2020 | New York, NY

Sermo Reports: Only 52% of US Physicians Say The Country Has Passed or Reached Outbreak Peak; 73% Recommend Keeping Restrictions

Majority of Physicians in Many COVID-19 Hotspots Including Korea, Spain, China and Italy Believe Their Countries Have Passed or Reached Outbreak Peak

Kentucky is the Only US State Where More Than 50% of Physicians Recommend Lifting Restrictions Within 2 Weeks

April 23, 2020 | New York, NY

Sermo reports jury is still out on Remdesivir; 31% of physicians who have used Remdesivir rate it as highly effective; 31% rate it with low effectiveness; 38% rate it as somewhere in the middle

Plasma rated as most safe and effective treatment; 57% of physicians who have used Plasma rate it as highly effective; 60% rate it as safe

Efficacy of treatments as seen by 430 COVID Supertreaters (physicians who’ve treated 20+ COVID patients)

April 22, 2020 | New York, NY

Sermo Reports: Two-Thirds of U.S. Physicians Believe COVID-19 Testing is Below the Level Needed

As of April 15, 30% of U.S. physicians vs. 60% in Europe reported getting test results back within a day

April 17, 2020 | New York, NY

Sermo Reports: One-Quarter of Global Physicians Agree That Healthcare Workers Should Take Hydroxychloroquine to Prevent COVID-19 Infections; Use of Hydroxychloroquine in Prophylaxis and Even in Undiagnosed Suspected Patient Cases is Seen

Sermo’s Barometer studies have polled over 20,000 physicians globally regarding COVID-19

April 15, 2020 | New York, NY

Sermo Reports Week 3 Results: Globally 17% Point Increase in COVID Treaters Who Have Used Hydroxychloroquine (33%-50%) and Azithromycin (41%-58%)

Percentage of New York Physicians Who Have Used Hydroxychloroquine Nearly Doubled, Italian and French Physicians Jumped 30% Points + Over 2 Weeks

Plasma Still Perceived as Most Effective but Not Widely Used

Perception of Hydroxychloroquine’s Efficacy is Significantly Higher Among Physicians in Europe and China vs US Physicians (50% vs 29%)